Skip to content

Clinical trials

Completed Attention Deficit Disorder with Hyperactivity trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Attention Deficit Disorder with Hyperactivity Status: Completed Country / region: Canada Clear all

52 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20032
20042
20053
20063
20083
20093
20105
20111
20123
20134
20145
20161
20183
20194
20211
20222
20233
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed52

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company7
Shire5
University of British Columbia5
The Hospital for Sick Children4
Rhodes Pharmaceuticals, L.P.3
University of Toronto3
IWK Health Centre2
JPM van Stralen Medicine Professional2
McGill University2
BioMarin Pharmaceutical1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Attention Deficit Disorder with Hyperactivity52
Anxiety Disorders3
Sleep Initiation and Maintenance Disorders3
Autism Spectrum Disorder2
Spasm2
Agoraphobia1
Attention Deficit and Disruptive Behavior Disorders1
Bipolar Disorder1
Bulimia1
Cerebral Palsy1

Trials

Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.